Dianna is a Partner of Cathay Capital. Prior to this role, she held positions at investment funds, including Pivotal Bioventure, Fountainvest Partners, and Fidelity Growth Partners, with over 14 years of investment experience. Before entering the investment sector, Dianna held senior roles in global pharmaceutical companies. She served as Vice President of Business Development and New Product Planning at Boehringer Ingelheim (BI), where she facilitated BI’s strategic product collaboration with Eli Lilly in China’s diabetes market. She worked as Director of Business Development for the Asia-Pacific region at Baxter International. Earlier in her career, she spent 7 years Boston Consulting Group (BCG) and McKinsey & Company, serving as a core member and Engagement Manager in Healthcare practice. Dianna holds Master of International Finance from East China Normal University and MBA from the Wharton School of the University of Pennsylvania.